Share this Post!

All comments shall be forwarded to [email protected]. no later until 10 July 2020.


The general objective of this Circular is to provide a clear and consistent procedure for the safety of FDA employees and clients in order to prevent the spread of infectious diseases such as COVID-19 in the workplace.

Specifically, it aims to:
2.1 Limit foot traffic;
2.2 Limit face to face interaction by encouraging online transactions.

to continue reading, click the attachment below…

Attachment:->Draft for Comments New Normal Operational Guidelines of FDA at the FDAC